Colchicine protects against hyperoxic lung injury in neonatal rats

Neonatology

Volumn 102, Issue 4, 2012, Pages 265-269

  Ozdemir, Ramazan ^a   Yurttutan, Sadik ^b   Talim, Beril ^c   Uysal, Bülent ^d   Erdeve, Omer ^e   Oguz, Serife Suna ^b   Dilmen, Ugur ^b,f  

^a INONU UNIVERSITY   (Turkey)

^b Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

^e ANKARA UNIVERSITY   (Turkey)

^f YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

Bronchopulmonary dysplasia; Colchicine; Glutathione peroxidase; Hyperoxia; Superoxide dismutase; Tumor necrosis factor

Indexed keywords

COLCHICINE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 1BETA; MALONALDEHYDE; OXYGEN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; HYPEROXIA; LUNG DYSPLASIA; LUNG INJURY; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; RAT;

ACUTE LUNG INJURY; ANIMALS; ANIMALS, NEWBORN; ANIMALS, SUCKLING; ANTIOXIDANTS; COLCHICINE; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE PEROXIDASE; HYPEROXIA; INTERLEUKIN-1BETA; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PULMONARY ALVEOLI; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 84865281049     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000341424     Document Type: Article

References (26)

1. Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729. (Pubitemid 32578778)
2. Ozdemir R, Erdeve O, Dizdar EA, Oguz SS, Uras N, Saygan S, Karabulut E, Dilmen U: Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum -positive preterm infants. Pediatrics 2011; 128:e1496-e1501.
3. Reyburn B, Martin RJ, Prakash YS, MacFarlane PM: Mechanisms of injury to the preterm lung and airway: Implications for longterm pulmonary outcome. Neonatology 2012; 101: 345-352.
4. Groneck P, Speer CP: Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 1995; 73: 1-3.
5. Van Marter LJ: Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 2009; 14: 358-366.
6. Polglase GR, Dalton RG, Nitsos I, Knox CL, Pillow JJ, Jobe AH, Moss TJ, Newnham JP, Kallapur SG: Pulmonary vascular and alveolar development in preterm lambs chronically colonized with Ureaplasma parvum . Am J Physiol Lung Cell Mol Physiol 2010; 299: 232-241.
7. Viscardi RM, Atamas SP, Luzina IG, Hasday JD, He JR, Sime PJ, Coalson JJ, Yoder BA: Antenatal Ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung. Pediatr Res 2006; 60: 141-146. (Pubitemid 44297582)
8. Terkeltaub R: Colchicine update: 2008. Semin Arthritis Rheum 2009; 38: 411-419.
9. Das D, Pemberton PW, Burrows PC, Gordon C, Smith A, McMahon RF, Warnes TW: Antioxidant properties of colchicine in acute carbon tetrachloride induced rat liver injury and its role in the resolution of established cirrhosis. Biochim Biophys Acta 2000; 1502: 351-362.
10. Dunnill MS: Quantitative methods in the study of pulmonary pathology. Thorax 1962; 17: 320-328.
11. Ballard HO, Bernard P, Qualls J, Everson W, Shook LA: Azithromycin protects against hyperoxic lung injury in neonatal rats. J Investig Med 2007; 55: 299-305. (Pubitemid 350205424)
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
13. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358. (Pubitemid 9194347)
14. Sun Y, Oberley LW, Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
15. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
16. Wright CJ, Kirpalani H: Targeting inflammation to prevent bronchopulmonary dysplasia: Can new insights be translated into therapies? Pediatrics 2011; 128: 111-126.
17. Kazzi SN, Kim UO, Quasney MW, Buhimschi I: Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 2004; 114:e243-e248.
18. Merritt TA, Deming DD, Boynton BR: The 'new' bronchopulmonary dysplasia: Challenges and commentary. Semin Fetal Neonatal Med 2009; 14: 345-357.
19. Speer CP: Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009; 95: 353-361.
20. Ben-Chetrit E, Bergmann S, Sood R: Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: A possible new outlook through microarray analysis. Rheumatology 2006; 45: 274-282. (Pubitemid 43372840)
21. Saugstad OD, Sejersted Y, Solberg R, Wollen EJ, Bjørås M: Oxygenation of the newborn: A molecular approach. Neonatology 2012; 101: 315-325.
22. Saugstad OD, Aune D: In search of the optimal oxygen saturation for extremely low birth weight infants: A systematic review and meta-analysis. Neonatology 2011; 100: 1-8.
23. Thomas W, Speer CP: Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia - what is the evidence? Neonatology 2008; 94: 150-159.
24. Reiter RJ, Tan DX, Osuna C, Gitto E: Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 2000; 7: 444-458.
25. Almario B, Wu S, Peng J, Alapati D, Chen S, Sosenko IR: Pentoxifylline and prevention of hyperoxia-induced lung-injury in neonatal rats. Pediatr Res 2012; 71: 583-589.
26. Margraf LR, Tomashefski JF Jr, Bruce MC, Dahms BB: Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis 1991; 143: 391-400.